Securities Registration: Employee Benefit Plan (s-8)
July 07 2014 - 4:21PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on July 7, 2014
Registration No. 333
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
BG MEDICINE, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
|
|
04-3506204
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
880 Winter Street, Suite 210, Waltham, Massachusetts
|
|
02451
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
BG MEDICINE, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN
BG MEDICINE, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN
(Full Titles of the Plans)
Paul R. Sohmer, M.D.
President and Chief Executive Officer
BG Medicine, Inc.
880
Winter Street, Suite 210
Waltham, Massachusetts 02451
(781) 890-1199
(Name,
Address and Telephone Number, Including Area Code, of Agent for Service)
Copies to:
William T. Whelan, Esq.
Linda K. Rockett, Esq.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, Massachusetts 02111
(617) 542-6000
Facsimile: (617) 542-2241
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting
company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
x
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of Securities
to be Registered
|
|
Amount
to be
Registered(1)
|
|
Proposed
Maximum
Offering Price
Per
Share(2)
|
|
Proposed
Maximum
Aggregate
Offering Price(2)
|
|
Amount of
Registration Fee
|
Common Stock, par value $0.001 per share
|
|
494,990 shares
|
|
$1.08
|
|
$534,589.20
|
|
$68.86
|
|
|
(1)
|
The number of shares of common stock, par value $0.001 per share (Common Stock), of BG Medicine, Inc. (the Registrant) stated above consists of (a) 449,991 additional shares of Common
Stock reserved under the BG Medicine, Inc. 2010 Employee, Director and Consultant Stock Plan (the 2010 Stock Plan) as a result of the automatic increase in shares reserved thereunder on January 1, 2014 pursuant to the terms of the
2010 Stock Plan; and (b) 44,999 additional shares of Common Stock reserved under the BG Medicine, Inc. 2010 Employee Stock Purchase Plan (the 2010 ESPP and together with the 2010 Stock Plan, the Plans) as a result
of the automatic increase in shares reserved thereunder on January 1, 2014 pursuant to the terms of the 2010 ESPP. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the Securities Act), this
Registration Statement covers, in addition to the number of shares stated above, an indeterminate number of shares which may be subject to grant or otherwise issuable after the operation of certain
anti-dilution
and other provisions of the Plans.
|
(2)
|
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act. The offering price per share and the aggregate offering
price for the additional shares reserved for future grant or issuance under the 2010 Stock Plan and additional shares reserved for future issuance under the 2010 ESPP, are based on the average ($1.075) of the high and the low price of
Registrants Common Stock as reported on The NASDAQ Capital Market as of a date (July 1, 2014) within five business days prior to filing this Registration Statement.
|
This Registration Statement registers additional securities of the same class as other securities for which
the registration statement filed on Form S-8 (SEC File No. 333-172208) of the Registrant is effective. The information contained in the Registrants registration statement on Form S-8 (SEC File No. 333-172208) is hereby incorporated
by reference pursuant to General Instruction E.
PART II
Item 8. Exhibits.
The Index of
Exhibits immediately following the signatures to this Registration Statement is incorporated herein by reference.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Waltham, Massachusetts on July 7, 2014.
|
|
|
BG M
EDICINE
, INC.
|
|
|
By
|
|
/s/ Paul R. Sohmer, M.D.
|
|
|
Paul R. Sohmer, M.D.
|
|
|
President and Chief Executive Officer
|
Each person whose signature appears below constitutes and appoints Paul R. Sohmer, M.D. and Stephen P.
Hall, and each of them singly, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for him and in his name, place and stead, and in any and all capacities, to sign any and all
amendments (including post-effective amendments) to this Registration Statement on Form S-8 of BG Medicine, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that the attorneys-in-fact and agents or any of each of them or their substitute may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
|
|
|
|
|
|
|
Signatures
|
|
Title
|
|
Date
|
|
|
|
|
By:
|
|
/s/ Paul R. Sohmer
Paul R. Sohmer, M.D.
|
|
President and Chief Executive Officer (principal executive officer) and Director
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Stephen P. Hall
Stephen P. Hall
|
|
Executive Vice President, Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer)
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Noubar B. Afeyan, Ph.D.
Noubar B. Afeyan, Ph.D.
|
|
Director
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Harrison Bains
Harrison M. Bains
|
|
Director
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Stéphane Bancel
Stéphane Bancel
|
|
Chairman of the Board of Directors
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Timothy Harris, Ph.D., D.Sc.
Timothy Harris, Ph.D., D.Sc.
|
|
Director
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Stelios Papadopoulos, Ph.D.
Stelios Papadopoulos, Ph.D.
|
|
Director
|
|
July 7, 2014
|
|
|
|
|
By:
|
|
/s/ Brian Posner
Brian Posner
|
|
Director
|
|
July 7, 2014
|
INDEX OF EXHIBITS
|
|
|
Exhibit
Number
|
|
Description
|
|
|
5.1
|
|
Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as to the legality of shares being registered.
|
|
|
23.1
|
|
Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in opinion of counsel filed as Exhibit 5.1).
|
|
|
23.2
|
|
Consent of Deloitte & Touche LLP.
|
|
|
24.1
|
|
Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement).
|
BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart
From Jul 2023 to Jul 2024